ESMO26: Lunit SCOPE studies highlight AI-based pathology benefit
Data from five studies involving Lunit’s SCOPE platform have demonstrated how artificial intelligence (AI)-based quantitative pathology can support research across…
News
St Luke’s deploys hellocare.ai platform across Idaho sites in US
UK government confirms indefinite EU CE mark recognition
Edwards secures FDA approval for tricuspid valve repair system
Intuitive’s shares fall 8% after tempering 2026 procedural growth outlook
AMA weighs in on FDA’s regulatory proposal for GenAI-based medtech
IceCure enrols initial patients for ProSense cryoablation trial in US
Abbott secures CE Mark for Cologuard Plus cancer test
